Antibacterial activities of iron chelators against common nosocomial pathogens.
about
Iron and zinc exploitation during bacterial pathogenesisIron homeostasis in host defence and inflammationTransferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infectionsOverexpression of fetA (ybbL) and fetB (ybbM), Encoding an Iron Exporter, Enhances Resistance to Oxidative Stress in Escherichia coli.The utility of iron chelators in the management of inflammatory disorders.Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence.Unravelling the Genome-Wide Contributions of Specific 2-Alkyl-4-Quinolones and PqsE to Quorum Sensing in Pseudomonas aeruginosaBiofilm inhibitors targeting the outer membrane protein A of Pasteurella multocida in swine.Escherichia coli Free Radical-Based Killing Mechanism Driven by a Unique Combination of Iron Restriction and Certain Antibiotics.Thalassosamide, a Siderophore Discovered from the Marine-Derived Bacterium Thalassospira profundimaris.Mind "De GaPP": in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms.New insights into the bacterial RNA polymerase inhibitor CBR703 as a starting point for optimization as an anti-infective agent.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates.A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity.An In Vitro Comparison of PMMA and Calcium Sulfate as Carriers for the Local Delivery of Gallium(III) Nitrate to Staphylococcal Infected Surgical SitesIn vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.Reply to "The Dual personality of iron chelators: growth inhibitors or promoters?".Acinetobacter baumannii Infection in Transfusion Dependent Thalassemia Patients with Sepsis.The dual personality of iron chelators: growth inhibitors or promoters?Rapid evolution of a bacterial iron acquisition system.Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria.Iron at the Centre of Candida albicans Interactions.Iron chelation increases the tolerance of Escherichia coli to hyper-replication stress.Antimicrobial Activity of Gallium Compounds on ESKAPE PathogensModulating Iron for Metabolic Support of TB Host DefenseNovel Iron-Chelator DIBI Inhibits Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics
P2860
Q28082191-C72E21CF-7E21-49AC-BBB9-A3D3B53F7002Q28083811-F87FF149-AB2A-4159-860D-2365ED48DD24Q28084708-1518160C-1BCB-4C12-A841-D9EB629048C6Q34987803-3AE9DD49-B701-4BAF-94E1-FBC2BEA19F57Q35283429-2E670D15-342E-4EC5-9E8D-3A744A8F9A07Q35736631-EABC791A-6124-4854-8549-572353B52F69Q36026123-E5064620-412B-45F6-AA41-8263D122E9E4Q36194223-79DE19C3-0ED1-4A37-BC4F-46F4F7049A07Q36205195-D80ABE08-8FC7-45CC-980F-3E3C8F75FF2EQ36227416-3182A4BE-6C81-4F3F-8966-2877418A432CQ38608624-5C277299-999D-460F-B5A9-C0178FBD1186Q38902883-6F00FAD5-C4E6-463E-8F94-32026F2B0B30Q38995793-2DF80B16-92C0-4516-970F-3E28AAFDFFBFQ39038590-458F201C-3B05-40B1-87CD-728AAE2D7753Q39197564-16B58137-9453-4B05-B771-5F8073225A6AQ39649887-9DB9F463-4EB3-4FAA-937A-2552E952E7CBQ40257070-3BDACFDC-305F-40A7-A6B3-B0AAA1159C75Q40788328-E4ACDB8E-B6C2-4CC8-9152-8BE28F422DE9Q41571185-24BBD3CF-6FE5-4E29-B938-8D58A36A2DACQ42906636-13F1E614-7493-44F3-8A15-A8AFF7FB7F31Q43049741-DB93CC8C-4236-4B81-BD6D-91E1304F4E83Q43188124-C4877EDC-6413-4BBE-9273-5B3AC94D348CQ48142477-6F4C8FA4-76DD-4A49-A9C6-EB67DD564B72Q49387383-6EDE49A3-E707-41E7-BF72-08F71C538F87Q55167938-F5718972-7574-4FC1-9AFF-1FD9619A5932Q55604192-765E06A4-3891-4D21-B02F-4F885C62F950Q57158916-314961E5-8930-4FC4-A270-F7CFF31083E1Q58122083-9EB6A2B3-6664-4E83-B059-672AD4E26092Q58781076-7CABA98D-9F6D-4561-AA66-692E84608379
P2860
Antibacterial activities of iron chelators against common nosocomial pathogens.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antibacterial activities of iron chelators against common nosocomial pathogens.
@en
Antibacterial activities of iron chelators against common nosocomial pathogens.
@nl
type
label
Antibacterial activities of iron chelators against common nosocomial pathogens.
@en
Antibacterial activities of iron chelators against common nosocomial pathogens.
@nl
prefLabel
Antibacterial activities of iron chelators against common nosocomial pathogens.
@en
Antibacterial activities of iron chelators against common nosocomial pathogens.
@nl
P2093
P2860
P356
P1476
Antibacterial activities of iron chelators against common nosocomial pathogens.
@en
P2093
Brendan W Corey
Daniel V Zurawski
David W Craft
Mitchell G Thompson
Yuanzheng Si
P2860
P304
P356
10.1128/AAC.01197-12
P407
P577
2012-07-30T00:00:00Z